The Prevalence of Asymptomatic Microscopic Hematuria in Women with Pelvic Organ Prolapse

Abstract

of $789 per QALY and robotic had a CE ratio of $1,092 per QALY; the incremental CE ratio per additional QALY was $9,496. Incremental CE ratio was $17,152 per additional QALY. Sensitivity analysis on all utilities, cost estimates and complication estimates did not reach plausible thresholds. Conclusion: Uphold vaginal support systemwas more cost-effective than robotic sacrocolpopexy even when the cost of the robot itself was not factored in.